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Abstract
Background: The polyene macrolide amphotericin B is pro-
duced by Streptomyces nodosus ATCC14899. Amphotericin B is a
potent antifungal antibiotic and has activity against some viruses,
protozoans and prions. Treatment of systemic fungal infections
with amphotericin B is complicated by its low water-solubility and
side effects which include severe nephrotoxicity. Analogues with
improved properties could be generated by manipulating ampho-
tericin biosynthetic genes in S. nodosus.
Results : A large polyketide synthase gene cluster was cloned
from total cellular DNA of S. nodosus. Nucleotide sequence
analysis of 113 193 bp of this region revealed six large polyketide
synthase genes as well as genes for two cytochrome P450 enzymes,
two ABC transporter proteins, and genes involved in biosynthesis
and attachment of mycosamine. Phage KC515-mediated gene
disruption was used to show that this region is involved in
amphotericin production.
Conclusions: The availability of these genes and the develop-
ment of a method for gene disruption and replacement in S.
nodosus should allow production of novel amphotericins. A panel
of analogues could lead to identification of derivatives with
increased solubility, improved biological activity and reduced
toxicity. ß 2001 Elsevier Science Ltd. All rights reserved.
Keywords: Amphotericin B; Polyketide synthase; Gene disruption;
Streptomyces nodosus
1. Introduction
The polyene macrolide amphotericin B is a medically
important antifungal antibiotic that is produced by Strep-
tomyces nodosus [1]. Polyenes disrupt eukaryotic cell mem-
branes after complexing with sterols to form channels that
allow loss of small molecules and ions and ultimately
cause cell death [2]. Amphotericin B is selectively toxic
towards fungal cells because it shows a high a⁄nity for
ergosterol, the predominant sterol in fungal cell mem-
branes. However, the drug also interacts to a lesser extent
with cholesterol in mammalian cell membranes and has
many severe side e¡ects, especially nephrotoxicity. In spite
of these adverse e¡ects, amphotericin B is still the most
important antibiotic for the treatment of serious systemic
fungal infections in humans.
In addition to its antifungal properties, amphotericin B
displays a number of other biological activities that may
result from its interaction with sterols [3]. The drug inhib-
its infection of cultured cells by human immunode¢ciency
virus (HIV) [4]. The envelopes of these virus particles have
a higher cholesterol:phospholipid ratio than host cell
membranes [5]. Amphotericin B also delays the onset of
prion disease symptoms in animal models [6]. Polyenes
may interfere with formation of abnormal isoforms of
prion proteins during tra⁄cking of sterol-rich membrane
microdomains that contain these glycosylphosphatidylino-
sitol-anchored proteins [7]. Amphotericin B is also active
against Leishmania, a protozoal parasite that contains er-
gosterol precursors in its membranes [3].
The problems associated with amphotericin B are re-
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duced when liposomal formulations of the drug are ad-
ministered [1]. Chemical modi¢cation has also yielded bio-
active derivatives with increased water-solubility and re-
duced toxicity [3]. Further improvements could be made
by investigating a wider range of analogues. These could
be generated by manipulating amphotericin biosynthesis in
S. nodosus.
The carbon chains of polyenes are assembled from ace-
tate and propionate units by polyketide synthases (PKSs)
[8]. Polyketide biosynthesis begins with the decarboxyla-
tive condensation of a dicarboxylic acid extender unit with
a starter acyl unit to form a L-ketoacyl intermediate. With
complex macrolide polyketides, the L-ketone group may
be converted to an alcohol, enoyl or methylene group
before another extender unit is added in the next cycle
of chain extension. The ¢nal product is a unique function-
alised acyl chain that may cyclise and undergo further
modi¢cation by hydroxylation, methylation and glycosyl-
ation.
Studies on erythromycin biosynthetic genes ¢rst re-
vealed that complex PKSs contain a synthase unit or mod-
ule for every cycle of chain extension [9,10]. Within each
module, an acyl transferase (AT) selects the extender unit
and a ketosynthase (KS) and an acyl carrier protein (ACP)
carry out the condensation. Ketoreductase (KR), dehydra-
tase (DH) and enoyl reductase (ER) enzymes may also be
present that determine the extent of L-carbonyl group pro-
cessing. These enzymes exist as domains within giant mul-
tienzyme polypeptides that may contain multiple modules
[11].
Biosynthetic gene clusters have now been investigated
for several macrolide polyketides. These include avermec-
tin [12], oleandomycin [13], rapamycin [14], FK506 [15]
and rifamycin [16]. Manipulation of these genes is a prom-
ising approach towards production of novel compounds
with improved properties. These studies have now been
extended to polyene PKSs. Criado et al. sequenced a
Streptomyces griseus gene for a p-aminobenzoic acid syn-
thase that functions in synthesis of the starter unit for the
aromatic heptaene candicidin [17]. Hu et al. cloned the
genes responsible for synthesis of FR-008, a polyene that
is identical in structure to candicidin except for the pres-
ence of an unusual sugar in place of mycosamine [18].
Aparicio et al. cloned and sequenced the genes responsible
for the 26-membered tetraene pimaricin [19,20]. The nys-
tatin biosynthetic gene cluster has been completely se-
quenced by Brautaset et al. [21].
The structure of amphotericin B [22] suggests that the
polyketide precursor is synthesised from the following se-
quence of starter and extender units : AP2A8PA7, where A
is acetate and P is propionate (Fig. 1). This has been
con¢rmed by chemical labelling experiments carried out
Fig. 1. Biosynthesis of amphotericin B. The polyketide precursor is assembled from acetate and propionate units [23]. After cyclisation, the macrolac-
tone ring is hydroxylated at C8, the hydroxyl group at C19 is mycosaminylated and the propionate-derived C41methyl group is oxidised to form the
exocyclic carboxyl group. The order in which these modi¢cations occur is unknown. In the co-metabolite amphotericin A, the double bond between
C28 and C29 is reduced.
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by Rawlings and coworkers [23]. After cyclisation, the
macrolactone core undergoes three post-polyketide modi-
¢cations. These are addition of a mycosamine sugar, hy-
droxylation at C8 and oxidation of a methyl branch (C41)
to a carboxyl group. It is not known whether these late
steps occur in a preferred order. S. nodosus also produces
a co-metabolite amphotericin A. This is identical to am-
photericin B except that the C28^C29 double bond is re-
duced.
In this paper we report the cloning and sequencing of
amphotericin biosynthetic genes from S. nodosus. In addi-
tion we show that phage KC515 transduction can be used
to introduce DNA into this organism for gene disruption
and replacement. This provides the prerequisites for engi-
neered biosynthesis of amphotericin analogues.
2. Results and discussion
2.1. Cloning and sequencing of amphotericin biosynthetic
genes
The strategy for cloning the amphotericin biosynthetic
genes involved the use of a heterologous probe to isolate
PKS genes from S. nodosus. A cosmid library was con-
structed from total cellular DNA. Positive clones were
identi¢ed using a probe derived from the eryAII gene
[9,10]. Cosmid DNA was puri¢ed from these hybridising
clones and characterised by restriction analysis with
EcoRI, KpnI and BamHI. Overlapping clones were identi-
¢ed and initial contigs were extended by chromosome
walking experiments.
Fig. 2. Organisation of the amphotericin biosynthetic gene cluster. EcoRI and BamHI restriction sites are denoted by E and B. Gene designations and
proposed functions are listed in Table 1.
Table 1
Amphotericin biosynthetic genes in S. nodosus
Gene Protein Size, amino acids
amphG ABC transporter 606
amphH ABC transporter 607
amphDIII GDP-mannose-4,6-DH 344
amphI PKS protein, modules 9^14 9510
amphJ PKS protein, modules 15^17 5643
amphK PKS protein, module 18-TE 2034
amphL Cytochrome P450 monooxygenase 396
ORF1 Hypothetical protein 169
ORF2 Hypothetical protein 284
ORF3 Hypothetical protein 533
amphM Ferredoxin 65
amphN Cytochrome P450 monooxygenase 399
amphDII Sugar aminotransferase 352
amphDI Glycosyl transferase 483
amphA PKS protein, loading module 1412
amphB PKS protein, modules 1 and 2 3190
amphC PKS protein, modules 3^8 10910
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A series of cosmids was assembled that represented a
stretch of DNA containing approximately 100 kb of PKS
genes plus at least 15 kb of £anking sequence at either
end. This was large enough to accommodate the 18 exten-
sion modules anticipated for the amphotericin PKS. Each
region of this DNA was represented by at least two inde-
pendent cosmid clones. This indicated that the cloned
DNA was not rearranged.
Preliminary sequencing indicated that the cloned DNA
encoded a PKS that was capable of assembling the poly-
Fig. 3. Modular structure of the amphotericin PKS and intermediates in polyene biosynthesis. Non-functional DH and KR domains are shown as
dashed circles. The ER domain in module 5 is thought to be partially active. Reduction of the enoyl group in this cycle would lead to production of
amphotericin A.
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ketide precursor of amphotericin B. Complete sequencing
of the cluster was then undertaken. Three cosmids repre-
senting most of the cluster were sequenced completely.
Fragments from cosmids containing both £anking regions
were also sequenced.
The amphotericin cluster (Fig. 2, Table 1) is very similar
to the biosynthetic gene cluster for the structurally related
polyene nystatin [21]. Analogous genes appear in the same
order in both clusters. The corresponding genes show a
high degree of sequence identity. This suggests a relatively
recent common ancestry.
2.2. PKS genes
The amphotericin PKS contains bimodular, hexamodu-
lar, trimodular and single module proteins as shown in
Fig. 3. It is likely that nascent polyketide chains are
more e⁄ciently transferred between successive modules
that are covalently joined. The largest PKS proteins se-
quenced to date contain six modules, which may be the
upper limit. No heptamodular PKS proteins have yet been
identi¢ed. The ¢delity and processivity of bacterial protein
synthesis [24] may not be high enough to allow su⁄ciently
accurate translation of PKS genes of this size.
The amphA gene encodes a loading module with the
domain structure KSS^AT^DH^ACP. Direct linkage of
a DH to an ACP domain is unusual. The AT domain
has the signature sequence characteristic of a malonyl
transferase [25] and probably loads malonyl groups onto
the ACP domain. The KSS domain has a serine residue in
place of the conserved active site cysteine. This domain
may act as a decarboxylase that acts on malonyl-ACP to
generate acetyl starter units.
KS domains are converted to potent decarboxylases
when the active site cysteine is replaced with glutamine
[26,27]. KSQ enzymes appear in loading modules for other
macrolide PKSs and also in aromatic PKSs. KSQ domains
convert malonyl or methylmalonyl groups to acetyl or
propionyl starter units. This may represent an e⁄cient
means of delivering primers to KS1 (or KSK) and may
also allow for stricter control of starter unit selection
[26]. It is uncertain whether KSS domains are equally e⁄-
cient at generating primers. The active site cysteine-161 of
the KS domain of rat fatty acid synthase (FAS) has been
replaced with various amino acids [27]. The cysteineCser-
ine change gave a mutant enzyme that retained a low
residual condensation activity and had only a weak decar-
boxylase activity. In polyene PKSs the activity of the de-
carboxylase may have been attenuated so the rate of prim-
er delivery matches the overall rate of polyene synthesis by
the extension modules. The amphotericin KSS domain re-
tains the residues corresponding to histidine-303, aspar-
tate-311, glutamate-314, lysine-335 and histidine-340 in
the active site of Escherichia coli KSII [28]. In the evolu-
tion of the loading module the cysteineCserine change
requires only a single point mutation and may be su⁄cient
to give an adequate decarboxylase. However, this change
does not completely uncouple decarboxylation from C^C
bond formation in rat FAS. The rat mutant KSS generates
L-ketobutyryl groups that are o¡-loaded onto CoA [27].
This would represent a wasteful side reaction of AmphA
since these starter units do not appear in the major poly-
ene products made by S. nodosus. These considerations
indicate that conversion of the KSS domain to a KSQ
domain could improve the e⁄ciency of the AmphA load-
ing module and increase the yield of polyenes produced.
The DH domain in AmphA is presumably redundant
since it would not normally encounter a L-hydroxyacyl-
ACP substrate.
The AmphB protein contains the ¢rst two extension
modules. As anticipated, these modules both contain
methylmalonate-speci¢c AT domains and reductive loops
containing only KR domains. These modules are similar
to modules 1 and 2 of 6-deoxyerythronolide B synthase
(DEBS) [9,10] except that the amphotericin module 1 gen-
erates a 2S,3S-2-methyl-3-hydroxy butanoic acyl thioester
whereas DEBS module 1 generates a 2S,3R-2-methyl-3-
hydroxy pentanoic acyl chain. Amphotericin module 11
also generates a 2S,3S-2-methyl-3-hydroxyacyl chain.
However, sequence alignments provide no obvious clues
as to how KRs select a particular stereochemistry at C2
in the extended L-ketoacyl chain or how the stereochem-
ical outcome of the ketoreduction is determined.
AmphC is a hexamodular protein that assembles most
of the polyene unit of amphotericin. Modules 3^8 all con-
tain a DH^KR reduction loop except module 5 which has
DH^ER^KR. The interdomain region preceding ER5 is 45
amino acids shorter than its counterpart in the NysC pro-
tein and similar complete reduction loops in other PKS
proteins. The shorter interdomain may restrict movement
of the amphotericin ER5 domain so that some nascent
chains are transferred from ACP5 to KS6 before enoyl
reduction takes place. This kinetic competition might ex-
plain why S. nodosus produces amphotericin B as well as
amphotericin A, in which the C28^C29 double bond is
reduced. We cannot yet exclude the possibility that the
PKS produces exclusively the polyketide precursor of am-
photericin A, with amphotericin B being produced as a
result of reintroduction of the C28^C29 double bond by
a speci¢c desaturase. However, the shortened linker do-
main favours the hypothesis that two polyketides are
made as a result of a lapse in programming ¢delity that
results from a sluggish ER domain. A number of studies
have found that reduction domains can fail to act when
inserted into recombinant PKS modules. The ER domain
from DEBS did not operate when the entire reductive loop
from module 4 was relocated into a recombinant trimod-
ular tetraketide synthase [29]. An equivalent reductive
loop from the rapamycin PKS module 1 was fully func-
tional in the same context [30]. DEBS KR6 was also non-
functional when placed in module 2 of the DEBS1-TE
triketide lactone synthase [31]. These studies suggest that
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sequences £anking reduction domains can a¡ect their ac-
tion during cycles of chain extension.
The relative levels of amphotericins A and B could be
in£uenced by the overall rate of £ux through the PKS
assembly line. Complete inactivation of ER5 by gene re-
placement should give an S. nodosus strain that exclusively
synthesises amphotericin B, the more active antifungal
agent.
It is remarkable that the amphC gene is stable in spite of
its repetitive nature. The amphC coding sequences for the
various KS domains are very similar and contain stretches
of identical sequence of up to 250 bp. These regions ap-
pear to be limited enough to prevent instability resulting
from excision of DNA after homologous recombination
between direct repeats.
The amphI gene encodes another hexamodular protein
that incorporates modules 9 to 14. The protein is similar
to the NysI protein. Module 11 has a methylmalonate-
speci¢c AT domain and incorporates the methyl branch
that is oxidised to form the exocyclic carboxyl group. Only
a single non-functional reduction domain is present in the
entire protein. Module 13 has an inactive KR domain in
which three amino acids have been deleted from the
NADPH-binding motif.
The amphJ gene encodes modules 15 to 17. Modules 15
and 17 both contain DH^KR reductive loops. The struc-
ture of the polyketide suggests that neither of these DH
domains is functional. However, DH15 contains the con-
served HXXXGXXXXP motif found in active DH do-
mains [32]. It is possible that the interdomain linker re-
gions constrain domain movements so that access to the
substrate is denied. DH17 is clearly inactive since the ac-
tive site histidine is replaced by an arginine residue. Mod-
ule 16 contains a complete DH^ER^KR reductive loop.
The main di¡erence between the amphotericin and nysta-
tin PKSs is that the reductive loops are di¡erent in mod-
ules 15 and 16. In the Nys J protein module 15 contains a
complete reductive loop whereas modules 16 and 17 con-
tain DH^KR reductive loops in which the DH domains
must be non-functional although they contain conserved
active site motifs.
The presence of these non-functional DH domains sug-
gests that AmphJ could have arisen from the DNA coding
for modules 4^6 (Fig. 3) whereas NysJ could have arisen
from modules 5^7. A duplicated amphC or nysC gene may
have undergone deletions to remove modules on either
side of module 5. The ¢nal structures of the amphJ and
nysJ genes may not have stabilised until after the diver-
gence of the amphotericin and nystatin producers.
The amphK gene encodes module 18 and the chain-ter-
minating thioesterase domain. Module 18 also contains a
DH domain that is apparently non-functional.
2.3. Cytochrome P450 enzymes
The products of the amphL and amphN genes resemble
cytochrome P450 enzymes. Both proteins contain the two
sequences that are conserved in other P450s. These are the
O2-binding motif and the region containing a cysteine res-
idue that coordinates the haem iron [33]. The amphN gene
is adjacent to amphM which encodes a ferredoxin. The
AmphL and AmphN proteins probably carry out post-
polyketide modi¢cations during biosynthesis of amphoter-
icin. It is likely that one catalyses the hydroxylation at C8
and the other functions in oxidation of the C41 methyl
branch to a carboxyl group. During bile acid biosynthesis,
sterol 27-hydroxylase converts the C27 methyl group of
cholesterol ¢rst to a CH2OH group and then to a carboxyl
group [34]. There is therefore a precedent for a single
P450 oxidising a methyl group all the way to a carboxyl
group.
The AmphN and NysN proteins show 84% sequence
identity whereas the the AmphL and NysL proteins
show 71% sequence identity. It is likely that the more
homologous enzymes (AmphN and NysN) are involved
in formation of the carboxyl groups. AmphL and NysL
probably hydroxylate their macrolactone rings at C8 and
C10 respectively.
The pimaricin cluster also contains two genes for cyto-
chrome P450s, pimD and pimG [20]. PimG is similar to
AmphN and NysN whereas PimD is similar to AmphL
and NysL. Disruption of PimD led to synthesis of 4,5 de-
epoxypimaricin [35]. This supports the view that AmphL,
NysL and PimD oxidise carbon atoms within the polyol
regions whereas AmphN, NysN and PimG probably form
carboxyl groups.
Attempts were made to disrupt the amphN gene in an
e¡ort to test this hypothesis. However, two di¡erent re-
combinant KC515 phage containing internal fragments of
amphN failed to disrupt the chromosomal copy of the
gene. A single thiostrepton-resistant lysogen was obtained
that contained a large chromosomal deletion rather than a
clean disruption. This mutant did not produce a polyene
(E. Flood and P. Ca¡rey, unpublished results). It is pos-
sible that disruption of some late genes will lead to syn-
thesis of toxic or insoluble products that can not be ex-
ported from the cell. Further attempts to disrupt amphN
are in progress. Successful disruption of this gene could
result in biosynthesis of a valuable amphotericin analogue
with a methyl group in place of the exocyclic carboxyl
group. Chemical modi¢cation of amphotericin B has
shown that suppression of charge on the free carboxyl
group improves speci¢city towards ergosterol-containing
fungal membranes, although ester derivatives were neuro-
toxic [36,37].
Another interesting experiment would be to determine
whether AmphL can hydroxylate nystatin at C8 and
whether NysL can hydroxylate amphotericin B at C10.
Introduction of an extra hydroxyl group could improve
solubility of either polyene. However it may be that
both P450s recognise a region of the macrolactone ring
consisting of three methylene groups between two carbon
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atoms bearing hydroxyl groups, in which case only a sin-
gle hydroxylation would be possible.
2.4. Glycosylation
The AmphDI protein shows weak homology to UDP-
glucuronate transferases and probably functions in addi-
tion of mycosamine to the aglycone core of amphotericin.
Like the nystatin and pimaricin clusters, the amphoter-
icin cluster contain a gene (amphDIII) for a GDP-man-
nose-4,6-DH. This suggests that the biosynthetic pathway
to mycosamine (3,6-dideoxy-3-amino-D-mannose) involves
isomerisation of GDP-6-deoxy-4-ketomannose to GDP-6-
deoxy-3-ketomannose, followed by an amino transfer to
give GDP-mycosamine. This ¢nal step is probably cata-
lysed by AmphDII protein which is similar to aminotrans-
ferases involved in biosynthesis of perosamine (4,6-di-
deoxy-4-aminomannose).
There is no gene common to the amphotericin, nystatin
and pimaricin clusters that is likely to encode a GDP-6-
deoxy-4-ketomannose-3,4-isomerase. This is remarkable
because all of the other biosynthetic genes appear to be
located close to the PKS genes. It has been suggested that
the eryCII gene encodes a dTDP-6-deoxy-4-ketoglucose-
3,4-isomerase that functions in the biosynthesis of desos-
amine [38]. Homologous genes have been found in clusters
for other macrolides that are glycosylated with desos-
amine, mycaminose or daunosamine [38,39]. Biosynthesis
of all of these amino sugars involves 3,4-isomerisation of
dTDP-6-deoxy-4-ketoglucose [38]. These putative isomer-
ases are similar to cytochrome P450 monooxygenases but
lack the conserved cysteine residue that coordinates the
haem iron.
The polyene biosynthetic genes may provide a clue why
proteins resembling cytochrome P450s should act as
dTDP-ketosugar isomerases. The hemiketalic portion of
polyenes shows some similarity in overall shape to a deoxy
ketosugar hemiacetal. Hemiketals also form in other mac-
rolides. It is therefore possible that the EryCII protein and
its homologues arose from cytochrome P450s that act on
macrolides, retaining a binding site for a hemiacetal but
not the iron haem group. The prosthetic group would not
be required for the more facile isomerisation reaction. The
putative dTDP-ketosugar isomerases show a weak similar-
ity to AmphN which presumably binds to the hemiketal
part of the amphotericin precursor to oxidise the C41
methyl group.
The structure of perimycin A also suggests a link be-
tween P450s and isomerases. This aromatic heptaene is not
modi¢ed by P450s and has a methyl branch in place of the
exocyclic carboxyl group found in most other glycosylated
polyenes [40]. Perimycin A is also unusual among polyenes
in that it is glycosylated with perosamine rather than my-
cosamine. Perosamine is synthesised from GDP-6-deoxy-
4-ketomannose without isomerisation. The perimycin pro-
ducer therefore lacks both the P450 and the ketosugar
isomerase. This striking coincidence is consistent with
the notion that a GDP-mannose-6-deoxy-4-ketomannose-
3,4-isomerase may also have evolved from a P450 which is
absent from the perimycin producer. We are investigating
perimycin biosynthesis to determine whether there is a
signi¢cant association between glycosylation with peros-
amine and absence of a free carboxyl group.
The isomerisation step in mycosamine biosynthesis is
one of the last remaining questions in polyene biosynthe-
sis. It is likely that answers will come from further se-
quencing and gene disruptions together with rigorous
chemical analysis of polyene analogues.
2.5. Export
The AmphG and AmphH proteins show strong homol-
ogy to ATP-binding cassette (ABC) transporters. There is
only 25% sequence identity between AmphG and AmphH.
It is unclear why two di¡erent transporter proteins are
present. The nystatin and pimaricin transporters gene clus-
ters also contain two transporters each, NysG and NysH
[20], and PimA and PimB [21]. The most plausible start
codon for the amphG reading frame occurs 17 bp before
the stop codon for amphH. The 3P end of the nysH gene
also overlaps the apparent 5P end of nysG by 20 bp and
pimA similarly overlaps pimB by 23 bp.
Many bacterial ABC transporters are thought to func-
tion as homodimers [41]. It is possible that AmphG and
AmphH associate to form a heterodimer that exports am-
photericins from the producing cell. The polyene exporter
would then resemble the 170-kDa P-glycoprotein that con-
fers multidrug-resistance on eukaryotic tumour cells. The
P-glycoprotein has two transmembrane domains (each
composed of six K-helices) and two nucleotide-binding do-
mains [41]. This protein is capable of exporting a wide
range of structurally and functionally unrelated com-
pounds. It remains to be seen whether the amphotericin
transporter will export all of the analogues that could be
generated by engineered biosynthesis.
An ABC transporter confers self-resistance to the ion-
ophore tetronasin on the producing organism Streptomy-
ces longisporo£avus [42]. This transporter is thought to
actively pump ions back into cells that have been permea-
bilised by tetronasin. Polyene-producing streptomycetes
could require a similar self protection system if even trace
levels of exogenous sterols were to enter their membranes.
An alternative role for one of the ABC transporters could
be to a¡ord this protection.
2.6. Additional genes
Open reading frames (ORFs) 1^3 have no homologues
in the nystatin or pimaricin clusters. It is therefore unlikely
that these ORFs have an important role in polyene bio-
synthesis. ORF1 encodes a 170-amino acid protein with
39% sequence identity with a 13-kDa protein found in the
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mini-circle, a 2527-bp transposable element from Strepto-
myces coelicolor [43]. ORF1 may represent the remnants of
an integrated mini-circle because neither of the other two
mini-circle protein genes are present. ORF2 shows 38%
sequence identity and 55% similarity to a hypothetical
protein from the plant pathogenic bacterium Xylella fas-
tidiosa (accession number AAF82888). ORF3 shows 55%
identity with a hypothetical membrane protein from S.
coelicolor (accession number CAB44413.1).
Sequence analysis of the regions £anking amphH and
amphC has been carried out. No genes with an obvious
role in amphotericin biosynthesis were identi¢ed down-
stream from amphG. The nystatin cluster has a candidate
gene for a phosphopantetheinyl transferase in this region
but no homologous gene was found within 5 kb of amphG.
Sequence analysis of the region beyond amphC is still in-
complete although genes for phosphomannomutase, phos-
phomannoisomerase and GDP-mannose synthetase have
been found in this region (M. Oliynyk and P. Ca¡rey,
unpublished results). These function in synthesis of
GDP-mannose from fructose 6-phosphate, an intermediate
in glycolysis. This region also contains a number of ORFs
whose translation products resemble hypothetical proteins
of unknown function. Gene disruption experiments are in
progress to ascertain whether these have an essential role
in amphotericin biosynthesis.
2.7. Disruption of PKS genes
The PC31-derived actinophage KC515 was found to
form plaques on S. nodosus. This suggested that KC515-
mediated transduction could be used for introduction of
DNA for gene disruption and replacement. A 5182-bp
BamHI fragment from within the amphC gene (nucleotides
Fig. 4. Targeted disruption of the amphC gene. A: Schematic diagram showing integration of recombinant phage KC515-M7 DNA into the S. nodosus
chromosome by homologous recombination. PstI, BamHI and BglII restriction sites are denoted by P, B and Bg. Bg/B is a hybrid BglII^BamHI site.
The phage carries a 3.0-kb BamHI^BglII fragment from within the amphC gene (black rectangle). Integration results in loss of a 7-kb BglII^PstI chro-
mosomal fragment and formation of 8.8-kb and 3-kb BglII^PstI fragments. These fragments are drawn as heavy lines. B: Analysis of chromosomal
DNA by Southern hybridisation with 3-kb BglII^BamHI fragment probe. Lanes 1 and 2 contain BglII^PstI digests of chromosomal DNA from wild-
type S. nodosus and the disruption mutant, respectively. The positions of the 7.0-, 8.8- and 3.0-kb hybridising bands are indicated. The probe fragment
includes part of the coding sequence for a highly conserved KS domain and hybridises less strongly to other fragments even at high stringency. A faint
4.8-kb band in lane 2 may be derived from free phage DNA that loops out and replicates in a small proportion of the population.
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100297^105480 in the amphotericin cluster sequence) was
subcloned into pUC118. A 3012-bp BglII^BamHI subfrag-
ment (nucleotides 102468^105480) was excised from
pUC118 using BglII and PstI and subcloned between the
BamHI and PstI sites of KC515. This 3012-bp region con-
tains the coding sequence for part of module 7 (half of
KS7 plus AT7-DH7). The recombinant phage, KC515-
M7, was used to infect S. nodosus and lysogens were ob-
tained by selecting for the thiostrepton resistance gene
within the prophage DNA. Genomic DNA from a typical
lysogen was digested with several restriction enzymes and
analysed by Southern hybridisation (e.g. Fig. 4). This re-
vealed that the phage had integrated into the PKS gene.
The disruption mutant, S. nodosus DM7, did not produce
amphotericin B, con¢rming that the biosynthetic gene
cluster for this polyene had been cloned. Further evidence
supporting this conclusion was obtained from a second
gene disruption experiment.
A 2013-bp KpnI fragment from within the amphI gene
(nucleotides 9265 to 11278) was subcloned into pUC118.
A 1667-bp KpnI^BglII fragment of this plasmid contained
the coding sequence (nucleotides 9265 to 10918) for the
KR and ACP of module 9 and approximately half of the
KS of module 10. This DNA was excised as a BglII^PstI
fragment and subcloned between the BamHI and PstI sites
of KC515. The recombinant phage, KC515-M9, was used
to infect S. nodosus and thiostrepton-resistant lysogens
were selected. Analysis of genomic DNA from a typical
lysogen indicated that integration of a phage had dis-
rupted the PKS gene (data not shown). This mutant,
S. nodosus DM9, also failed to produce amphotericin B.
These results show that the cloned genes function in
amphotericin biosynthesis. The availability of at least
one method for manipulating these S. nodosus genes
should allow rational design of novel polyenes.
3. Signi¢cance
Amphotericin B is the most important drug for the
treatment of life-threatening fungal infections in humans.
The incidence of these infections has increased over the
past 20 years [44]. There is an urgent need to develop
amphotericin derivatives with reduced toxicity.
We have cloned the amphotericin biosynthetic genes
from S. nodosus and shown that phage KC515 can be
used to introduce DNA into this organism for gene dis-
ruption and replacement. This should allow engineered
biosynthesis of improved antifungal drugs. These novel
compounds could also be investigated as potential antivi-
ral, antiprion or antiparasitic agents.
The amphotericin PKS consists of 18 extension modules
and is one of the largest for which a sequence is available.
The amphotericin system can now be used to engineer the
biosynthesis of libraries of larger macrolide structures for
drug discovery.
4. Materials and methods
4.1. Bacterial strains
S. nodosus ATCC 14899 was used as the source of DNA in the
construction of a genomic library. E. coli strain XL1-Blue MR
was used as a host for propagation of cosmids and plasmids.
Streptomyces lividans 66 (John Innes strain 1326) was used for
propagation of phage KC515 [45].
4.2. Assays for amphotericin B production
For amphotericin production, S. nodosus was grown on fruc-
tose^dextrin medium [23] (fructose 20 g/l, dextrin 60 g/l, soya
£our 30 g/l CaCO3 10 g/l (pH 7.0)). Samples of the culture
were withdrawn at 12-h intervals and supernatants were assayed
for amphotericin by bioassay using Saccharomyces cerevisiae
NCYC 1006 as an indicator organism. Alternatively, 100-Wl sam-
ples of culture were mixed with 900-Wl volumes of dimethylsulph-
oxide and sonicated for 20 min. The extract was centrifuged and
the supernatant was diluted with methanol. The absorption spec-
trum was measured in the wavelength range 190^450 nm. Am-
photericin B gives four speci¢c absorption peaks at 346, 364, 382
and 405 nm [23]. Amphotericin A absorbs at 280, 292, 305 and
320 nm. Amphotericin B standard was obtained from Sigma.
4.3. Genetic procedures
Total cellular DNA was isolated from S. nodosus as described
[46]. The DNA was partially digested with Sau3A and fragments
in the 35^45-kb size range were isolated by sucrose density gra-
dient centrifugation [47]. These fragments were ligated to BamHI-
cut dephosphorylated pWE15 cosmid vector and packaged into
lambda phage particles using the Stratagene Gigapack II system.
The library was plated on E. coli XL1-Blue MR and clones were
screened by colony hydridisation using a probe derived from a
DNA fragment containing the entire eryAII gene sequence [32].
Labelling of probes with digoxigenin-dUTP and detection of hy-
bridising DNA were carried out using a Boehringer Mannheim
DIG DNA labelling and detection kit. For Southern hybridisa-
tion, DNA fragments were transferred to nylon membranes by
capillary transfer [47].
Cosmid and plasmid DNA was isolated using the alkaline-SDS
procedure [47]. Restriction enzyme digestions and ligations were
carried out using standard procedures. Competent E. coli cells for
transformation were prepared by the calcium chloride method
[47].
Methods for preparation of streptomycete spores and proto-
plasts were those described by Hopwood et al. [46]. Phage KC515
DNA was isolated using the small-scale method [46]. DNA frag-
ments ligated to KC515 DNA were introduced into S. lividans 66
protoplasts by transfection [46]. Recombinant phage were identi-
¢ed by PCR using primers speci¢c for the cloned insert.
PCRs were carried out with Taq polymerase as described [47]
using a Perkin Elmer GeneAmp 2400 thermocycler. The oligonu-
cleotide primers were synthesised by GenoSys, Cambridge, UK.
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To obtain disruption mutants, recombinant phage were plated
on S. nodosus spores to give near con£uent lysis. After overnight
incubation, plates were overlaid with soft nutrient agar contain-
ing 50 Wg thiostrepton per ml. Thiostrepton-resistant lysogens
resulting from integration of the phage were streaked on tryptone
soya (TS) agar containing thiostrepton.
4.4. DNA sequencing
DNA sequencing was carried out at Biotica Technology Ltd.,
Cambridge, UK. Intact cosmids were partially digested with
Sau3A1 and fragments in the size range 1 to 2 kb were puri¢ed
by preparative agarose gel electrophoresis and subcloned into
BamHI-digested plasmid pBCSK+ (Stratagene). Plasmid sub-
clones were isolated using Qiagen columns. DNA concentrations
were measured using a Pharmacia Gene Quant spectrophotome-
ter. Automated sequencing was done on double-stranded DNA
templates by the dideoxynucleotide chain termination method
with an Applied Biosystems model 373A sequencer. Sequence
data obtained from single random subclones was assembled
into a single continuous sequence and edited using the GAP4.1
program of the STADEN gene analysis package [48]. DNA and
protein sequence homology searches of data bases were done
using the BLAST programme [49].
The DNA sequence has been deposited in the GenBank data-
base under the accession number AF357202.
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